Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers.

Dickson DW, Baker MC, Jackson JL, DeJesus-Hernandez M, Finch NA, Tian S, Heckman MG, Pottier C, Gendron TF, Murray ME, Ren Y, Reddy JS, Graff-Radford NR, Boeve BF, Petersen RC, Knopman DS, Josephs KA, Petrucelli L, Oskarsson B, Sheppard JW, Asmann YW, Rademakers R, van Blitterswijk M.

Acta Neuropathol Commun. 2019 Oct 8;7(1):150. doi: 10.1186/s40478-019-0797-0.

2.

Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial.

Hanna MG, Badrising UA, Benveniste O, Lloyd TE, Needham M, Chinoy H, Aoki M, Machado PM, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Auberson LZ, Wu M, de Vera A, Papanicolaou DA, Amato AA; RESILIENT Study Group.

Lancet Neurol. 2019 Sep;18(9):834-844. doi: 10.1016/S1474-4422(19)30200-5.

PMID:
31397289
3.

Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010-2015.

Raymond J, Oskarsson B, Mehta P, Horton K.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):413-420. doi: 10.1080/21678421.2019.1612435. Epub 2019 May 26.

PMID:
31131638
4.

A novel muscle cramp scale (MCS) in amyotrophic lateral sclerosis (ALS).

Mitsumoto H, Chiuzan C, Gilmore M, Zhang Y, Ibagon C, McHale B, Hupf J, Oskarsson B.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):328-335. doi: 10.1080/21678421.2019.1603310. Epub 2019 Apr 22. Erratum in: Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jun 11;:1.

PMID:
31007059
5.

Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity.

Zhang YJ, Guo L, Gonzales PK, Gendron TF, Wu Y, Jansen-West K, O'Raw AD, Pickles SR, Prudencio M, Carlomagno Y, Gachechiladze MA, Ludwig C, Tian R, Chew J, DeTure M, Lin WL, Tong J, Daughrity LM, Yue M, Song Y, Andersen JW, Castanedes-Casey M, Kurti A, Datta A, Antognetti G, McCampbell A, Rademakers R, Oskarsson B, Dickson DW, Kampmann M, Ward ME, Fryer JD, Link CD, Shorter J, Petrucelli L.

Science. 2019 Feb 15;363(6428). pii: eaav2606. doi: 10.1126/science.aav2606.

6.

Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients.

Woolley S, Goetz R, Factor-Litvak P, Murphy J, Hupf J, Lomen-Hoerth C, Andrews H, Heitzman D, Bedlack R, Katz J, Barohn R, Sorenson E, Oskarsson B, Filho AF, Kasarskis E, Mozaffar T, Nations S, Swenson A, Koczon-Jaremko A, Christodoulou G, Mitsumoto H.

Behav Neurol. 2018 Oct 31;2018:5969137. doi: 10.1155/2018/5969137. eCollection 2018.

7.

Amyotrophic Lateral Sclerosis: An Update for 2018.

Oskarsson B, Gendron TF, Staff NP.

Mayo Clin Proc. 2018 Nov;93(11):1617-1628. doi: 10.1016/j.mayocp.2018.04.007. Epub 2018 Jul 4. Review.

PMID:
30401437
8.

Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis.

Zhang YJ, Gendron TF, Ebbert MTW, O'Raw AD, Yue M, Jansen-West K, Zhang X, Prudencio M, Chew J, Cook CN, Daughrity LM, Tong J, Song Y, Pickles SR, Castanedes-Casey M, Kurti A, Rademakers R, Oskarsson B, Dickson DW, Hu W, Gitler AD, Fryer JD, Petrucelli L.

Nat Med. 2018 Aug;24(8):1136-1142. doi: 10.1038/s41591-018-0071-1. Epub 2018 Jun 25.

9.

Mexiletine for muscle cramps in amyotrophic lateral sclerosis: A randomized, double-blind crossover trial.

Oskarsson B, Moore D, Mozaffar T, Ravits J, Wiedau-Pazos M, Parziale N, Joyce NC, Mandeville R, Goyal N, Cudkowicz ME, Weiss M, Miller RG, McDonald CM.

Muscle Nerve. 2018 Mar 6. doi: 10.1002/mus.26117. [Epub ahead of print]

10.

National Study of Muscle Cramps in ALS in the USA.

Stephens HE, Joyce NC, Oskarsson B.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):32-36. doi: 10.1080/21678421.2016.1245755. Epub 2016 Dec 15. Erratum in: Amyotroph Lateral Scler Frontotemporal Degener. 2017 Aug;18(5-6):470.

11.

Myasthenia gravis exacerbation after discontinuing mycophenolate: A single-center cohort study.

Dimachkie MM, Abuzinadah AR, Barohn RJ, Oskarsson B, Rocke DM, Dengel K, Richman DP.

Neurology. 2016 Nov 8;87(19):2067-2068. No abstract available.

PMID:
27821567
12.

Longitudinal evaluation of upper extremity reachable workspace in ALS by Kinect sensor.

de Bie E, Oskarsson B, Joyce NC, Nicorici A, Kurillo G, Han JJ.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):17-23. doi: 10.1080/21678421.2016.1241278. Epub 2016 Nov 4.

PMID:
27813421
13.

Association Between Dietary Intake and Function in Amyotrophic Lateral Sclerosis.

Nieves JW, Gennings C, Factor-Litvak P, Hupf J, Singleton J, Sharf V, Oskarsson B, Fernandes Filho JA, Sorenson EJ, D'Amico E, Goetz R, Mitsumoto H; Amyotrophic Lateral Sclerosis Multicenter Cohort Study of Oxidative Stress (ALS COSMOS) Study Group.

JAMA Neurol. 2016 Dec 1;73(12):1425-1432. doi: 10.1001/jamaneurol.2016.3401.

14.

Phosphoglycerate mutase deficiency (glycogen storage disease X) caused by a novel variant in PGAM-M.

Koo B, Oskarsson B.

Neuromuscul Disord. 2016 Oct;26(10):688-690. doi: 10.1016/j.nmd.2016.08.002. Epub 2016 Aug 11.

PMID:
27612597
15.

Myasthenia gravis exacerbation after discontinuing mycophenolate: A single-center cohort study.

Oskarsson B, Rocke DM, Dengel K, Richman DP.

Neurology. 2016 Mar 22;86(12):1159-63. doi: 10.1212/WNL.0000000000002405. Epub 2016 Feb 5.

16.

Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort.

Murphy J, Factor-Litvak P, Goetz R, Lomen-Hoerth C, Nagy PL, Hupf J, Singleton J, Woolley S, Andrews H, Heitzman D, Bedlack RS, Katz JS, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Koczon-Jaremko BA, Mitsumoto H; ALS COSMOS.

Neurology. 2016 Mar 1;86(9):813-20. doi: 10.1212/WNL.0000000000002305. Epub 2016 Jan 22.

17.

Potential Environmental Factors in Amyotrophic Lateral Sclerosis.

Oskarsson B, Horton DK, Mitsumoto H.

Neurol Clin. 2015 Nov;33(4):877-88. doi: 10.1016/j.ncl.2015.07.009. Review.

18.

Upper extremity 3-dimensional reachable workspace assessment in amyotrophic lateral sclerosis by Kinect sensor.

Oskarsson B, Joyce NC, De Bie E, Nicorici A, Bajcsy R, Kurillo G, Han JJ.

Muscle Nerve. 2016 Feb;53(2):234-41. doi: 10.1002/mus.24703. Epub 2015 Dec 29.

19.

Synthesis of guanidinylated chitosan with the aid of multiple protecting groups and investigation of antibacterial activity.

Sahariah P, Óskarsson BM, Hjálmarsdóttir MÁ, Másson M.

Carbohydr Polym. 2015;127:407-17. doi: 10.1016/j.carbpol.2015.03.061. Epub 2015 Mar 30.

PMID:
25965500
20.

A case of familial ALS due to multi-system proteinopathy 1 and Huntington disease.

Oskarsson B, Wheelock V, Benatar M, Taylor JP, Joyce N, Chesak D, Jin LW.

Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar;16(1-2):124-6. doi: 10.3109/21678421.2014.952238. Epub 2014 Sep 10. No abstract available.

21.

ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics.

Mitsumoto H, Factor-Litvak P, Andrews H, Goetz RR, Andrews L, Rabkin JG, McElhiney M, Nieves J, Santella RM, Murphy J, Hupf J, Singleton J, Merle D, Kilty M, Heitzman D, Bedlack RS, Miller RG, Katz JS, Forshew D, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Lomen-Hoerth C, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Shefner JM, Andrews JA, Koczon-Jaremko BA; ALS COSMOS Study Group.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):192-203. doi: 10.3109/21678421.2013.864312. Epub 2014 Feb 24.

22.

ALS Untangled No. 20: the Deanna protocol.

ALSUntangled Group, Fournier C, Bedlack B, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Ostrow L, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, Dimachkie M, Wang Y, Wicks P, Heywood J, Novella S, Rowland LP, Pioro E, Kinsley L, Mitchell K, Glass J, Sathornsumetee S, Kwiecinski H, Baker J, Atassi N, Forshew D, Ravits J, Conwit R, Jackson C, Sherman A, Dalton K, Tindall K, Gonzalez G, Robertson J, Phillips L, Benatar M, Sorenson E, Shoesmith C, Nash S, Maragakis N, Moore D, Caress J, Boylan K, Armon C, Grosso M, Gerecke B, Wymer J, Oskarsson B, Bowser R, Drory V, Shefner J, Lechtzin N, Leitner M, Miller R, Mitsumoto H, Levine T, Russell J, Sharma K, Saperstein D, McClusky L, MacGowan D, Licht J, Verma A, Strong M, Lomen-Hoerth C, Tandan R, Rivner M, Kolb S, Polak M, Rudnicki S, Kittrell P, Quereshi M, Sachs G, Pattee G, Weiss M, Kissel J, Goldstein J, Rothstein J, Pastula D, Gleb L, Ogino M, Rosenfeld J, Carmi E, Oster C, Barkhaus P, Valor E.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):319-23. doi: 10.3109/21678421.2013.788405. Epub 2013 May 2. Review. No abstract available.

PMID:
23638638
23.

Motor neuron involvement in multisystem proteinopathy: implications for ALS.

Benatar M, Wuu J, Fernandez C, Weihl CC, Katzen H, Steele J, Oskarsson B, Taylor JP.

Neurology. 2013 May 14;80(20):1874-80. doi: 10.1212/WNL.0b013e3182929fc3. Epub 2013 May 1.

24.

Oculopharyngeal muscular dystrophy as a cause of progression of weakness in antibody positive myasthenia gravis.

Oskarsson B, Ringel SP.

Neuromuscul Disord. 2013 Apr;23(4):316-8. doi: 10.1016/j.nmd.2013.01.012. Epub 2013 Mar 1.

25.

Current pharmacologic management in selected neuromuscular diseases.

Skalsky AJ, Oskarsson B, Han JJ, Richman D.

Phys Med Rehabil Clin N Am. 2012 Nov;23(4):801-20. doi: 10.1016/j.pmr.2012.09.003. Epub 2012 Oct 17. Review.

PMID:
23137738
26.

Muscle biopsy evaluation in neuromuscular disorders.

Joyce NC, Oskarsson B, Jin LW.

Phys Med Rehabil Clin N Am. 2012 Aug;23(3):609-31. doi: 10.1016/j.pmr.2012.06.006. Review.

27.

Treatment of γ-aminobutyric acid B receptor-antibody autoimmune encephalitis with oral corticosteroids.

Goldenholz DM, Wong VS, Bateman LM, Apperson M, Oskarsson B, Akhtar S, Wheelock V.

Arch Neurol. 2012 Aug;69(8):1061-3. doi: 10.1001/archneurol.2012.197.

PMID:
22507884
28.

Myopathy: five new things.

Oskarsson B.

Neurology. 2011 Feb 15;76(7 Suppl 2):S14-9. doi: 10.1212/WNL.0b013e31820c3648. Review. No abstract available.

PMID:
21321346
29.

Using the Frontal Assessment Battery to identify executive function impairments in amyotrophic lateral sclerosis: A preliminary experience.

Oskarsson B, Quan D, Rollins YD, Neville HE, Ringel SP, Arciniegas DB.

Amyotroph Lateral Scler. 2010;11(1-2):244-7. doi: 10.3109/17482960903059588.

PMID:
19530013
30.

Neuromuscular hyperexcitability associated with acetylcholine receptor antibodies in a child.

Oskarsson B, Zawadzki L, Benke T, Quan D.

J Child Neurol. 2009 Jan;24(1):90-2. doi: 10.1177/0883073808320755. Epub 2008 Oct 20.

PMID:
18936193
31.

Stiff eyes in stiff-person syndrome.

Oskarsson B, Pelak V, Quan D, Hall D, Foster C, Galetta S.

Neurology. 2008 Jul 29;71(5):378-80. doi: 10.1212/01.wnl.0000319725.22925.b4. No abstract available.

PMID:
18663186
32.

Diagnostic abdominal paracentesis.

Gjessing J, Oskarsson BM, Tomlin PJ, Brock-Utne J.

Br Med J. 1972 Mar 4;1(5800):617-9.

Supplemental Content

Loading ...
Support Center